STOCK TITAN
  1. Home
  2. News
  3. LH

Labcorp Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends

BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022, to stockholders of record as of the close of business on August 18, 2022.

About Labcorp

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.

Investors: Chas Cook - 336-436-5076

Investor@Labcorp.com

Media: Christopher Allman-Bradshaw - 336-436-8263

Media@Labcorp.com

Source: Labcorp

Stock LH logo
Laboratory Corp. Of America Holdings

NYSE:LH

LH Rankings

#584 Ranked by Market Cap
#1736 Ranked by Stock Gains
#1633 Ranked by Dividends

LH Latest News

Apr 25, 2024
Labcorp Announces 2024 First Quarter Results
Apr 24, 2024
Labcorp Announces Winning Bid for Select Assets of Invitae
Apr 24, 2024
Invitae Enters into Agreement with Labcorp for Sale of Business
Apr 15, 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Apr 11, 2024
Labcorp Declares Quarterly Dividend

LH Stock Data

Diagnostic Imaging Centers
Health Care and Social Assistance
Link
Health Services, Services to the Health Industry, Manufacturing, Dental Laboratories
US
Burlington

About LH

recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.